QuickGun LifeScience is developing a patent pending formulation as an alternative to fast track Covid-19 vaccine program
BioSilver-CEP formulation ready for testing in Adhya BioScience Lab. QuickGun LifeScience is developing a patent pending formulation as an alternative to fast track Covid-19 vaccine program ANI | Updated: Dec 11, 2020 13:04 IST New Delhi [India], December 11 (ANI/SRV Media): The need for a preventive and curative vaccine to combat the growing Covid-19 virus is the need of the hour.With over 170 countries around the world in a race to develop the first vaccine for coronavirus, researchers and scientists are treading the path, not without challenges. A crit...
Source: aninews.in